Skip to content

Author

Yan-Fei Li

We have 2 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Deoxynivalenol triggers pyroptosis in intestinal epithelial cells via NLRP3 inflammasome activation mediated by the TLR4-NF-κB/p38 MAPK signaling pathway.

TLR4 inhibition with TLR4-IN-C34 confirmed that TLR4 acts as an upstream regulator controlling both NF-κB and p38 MAPK signaling, thus inhibiting NLRP3 inflammasome activation and alleviating pyroptosis.

Wang-Yong Yu, Ya-Fei Sun, Ming-Yue Wang et al. · 0 citations
Jul 2026

Chronic Kidney Disease Risk Posed by 1-Ethoxy-2,3-difluoro-4-(trans-4-propylcyclohexyl) Benzene (EDPrB): An AOP of mTOR-Mediated Autophagy Dysregulation.

This study demonstrates that exposure to EDPrB can induce inflammatory responses and fibrosis in human renal cortical proximal tubule epithelial cells (HK-2), and proposes an AOP framework focused on EDPrB-induced CKD, highlighting the renal risks of FLCMs and supports stricter environmental release regulations.

Chenjiao Miao, Binwen Zhang, Wang-Yong Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.